Back to results
US 12,060,583 B2Granted
Scalable chromatography process for purification of human cytomegalovirus
AssigneeMerck Sharp & Dohme Corp.
InventorsAdam Kristopeit, Janelle Konietzko, Wanli Ma, Katherine Phillips, Andrew Swartz, Sheng-Ching Wang, Marc D. Wenger, Matthew Woodling, Tiago Matos
Life of this patent
Estimating the term…
Abstract
The present invention relates to a scalable process for the purification of human cytomegalovirus particles from cell culture medium. In particular, the process involves a two step chromatography process starting with an anion exchange chromatography step followed by a polishing chromatography step selected from mixed mode chromatography or cation exchange chromatography.
Claims4
A method for the purification of HCMV from a cell culture medium comprising the steps of:
- a) harvesting cell culture medium from a culture of ARPE-19 cells infected with HCMV;
- b) subjecting the cell culture medium to nuclease treatment using an endonuclease at a concentration of 10-160 U/mL;
- c) clarifying the nuclease-treated cell culture medium using a 1.2 μm glass fiber filter to obtain a clarified cell culture medium;
- d) contacting the clarified cell culture medium comprising HCMV with an anion exchange chromatography membrane under conditions that allow the HCMV to bind to the anion exchange chromatography membrane and then eluting the HCMV from the anion exchange chromatography membrane to obtain an eluate;
- e) contacting the eluate with a mixed-mode chromatography resin which is a hydrophobic anion exchange chromatography resin having a molecular weight exclusion of about 700 kDa and then collecting the HCMV from the mixed mode chromatography resin to obtain purified HCMV;
- and
- f) performing tangential flow filtration on the purified HCMV collected from step e) to adjust to the desired concentration and buffer
- wherein the cells are grown on microcarriers;
- wherein the purified HCMV has at least 80% HCMV protein purity and/or a process yield of at least 40%;
- and
- wherein the HCMV is a recombinant genetically modified HCMV having a genomic sequence of SEQ ID NO:
- 1.
9 more elements
Dependencies are inferred from the claim text.